SCHEMBL7650033

SCHEMBL7650033

C1=Cc2cc3ccc(cc4nc(cc5ccc(cc1n2)[nH]5)-c1ccccc1-4)[nH]3.[Pd]

nearest known ligand 0.39

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ STAT3 P40763 1/20 0.39
▸ STAT1 P42224 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27308 0.98 STAT3 (0.40) STAT3STAT1
SCHEMBL2979039 0.98 STAT3 (0.40) STAT3STAT1
SCHEMBL29459652 0.98 STAT3 (0.40) STAT3STAT1
SCHEMBL16286470 0.96 STAT3 (0.39) STAT3STAT1
SCHEMBL9679890 0.96 STAT3 (0.39) STAT3STAT1
SCHEMBL457013 0.96 STAT3 (0.39) STAT3STAT1
SCHEMBL30713723 0.96 STAT3 (0.39) STAT3STAT1
SCHEMBL5144296 0.96 STAT3 (0.39) STAT3STAT1
SCHEMBL30713725 0.96 STAT3 (0.39) STAT3STAT1
SCHEMBL27538404 0.96 STAT3 (0.39) STAT3STAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101604107-A Be used to change the device of the wavelength coverage of spectrum SONY CORP (JP) 2009-12-16 — — CN claimed
CN-101556421-A A display system SONY CORP (JP) 2009-10-14 — — CN claimed
US-12616845-B2 Devices and related methods for light-based modulation of foreign body responses in living tissue KNOW BIO, LLC (US) 2026-05-05 — — US disclosed
US-20250176866-A1 IMPLANTABLE BIOSENSORS THE TEXAS A&M UNIVERSITY SYSTEM (US) 2025-06-05 — — US disclosed
EP-4559393-A1 DEVICE FOR MONITORING INTERSTITIAL LACTATE AND PH LEVELS Universidad de Cádiz (ES) 2025-05-28 — — EP disclosed
WO-2024018113-A1 DEVICE FOR MONITORING INTERSTITIAL LACTATE AND PH LEVELS UNIVERSIDAD DE CÁDIZ (ES) 2024-01-25 — — WO disclosed
EP-4157443-A1 DEVICES AND RELATED METHODS FOR LIGHT-BASED MODULATION OF FOREIGN BODY RESPONSES IN LIVING TISSUE KNOW Bio, LLC (US) 2023-04-05 — — EP disclosed
US-20210370088-A1 DEVICES AND RELATED METHODS FOR LIGHT-BASED MODULATION OF FOREIGN BODY RESPONSES IN LIVING TISSUE KNOW BIO, LLC 2021-12-02 — — US disclosed
WO-2021242805-A1 DEVICES AND RELATED METHODS FOR LIGHT-BASED MODULATION OF FOREIGN BODY RESPONSES IN LIVING TISSUE KNOW BIO, LLC (US) 2021-12-02 — — WO disclosed
CN-110050030-A Oxygen detection layers 哈美顿博纳图斯股份公司 2019-07-23 — — CN disclosed
US-20190000361-A1 IMPLANTABLE BIOSENSORS THE TEXAS A&M UNIVERSITY SYSTEM 2019-01-03 — — US disclosed
US-6207461-B1 DIAGNOSTICS; COMPOUND IS IRRADIATED WITH LIGHT TO PRODUCE LUMINESCENCE RADIATION, THEN CONTACT WITH OXYGEN QUENCHES INTENSITY NOVARTIS AG (CH) 2001-03-27 — — US disclosed
US-6207461-B1 DIAGNOSTICS; COMPOUND IS IRRADIATED WITH LIGHT TO PRODUCE LUMINESCENCE RADIATION, THEN CONTACT WITH OXYGEN QUENCHES INTENSITY NOVARTIS AG (CH) 2001-03-27 — — US disclosed
EP-0915883-A1 PROCESS FOR THE PREPARATION OF PLATINUM OR PALLADIUM BENZOPORPHYRINS AND PLATINUM OR PALLADIUM CYCLOHEXENOPORPHYRINS, INTERMEDIATES, AND AN OXYGEN SENSOR COMPRISING PLATINUM OR PALLADIUM CYCLOHEXENOPORPHYRIN Novartis AG (CH) 1999-05-19 — — EP disclosed
WO-1998003512-A1 PROCESS FOR THE PREPARATION OF PLATINUM OR PALLADIUM BENZOPORPHYRINS AND PLATINUM OR PALLADIUM CYCLOHEXENOPORPHYRINS, INTERMEDIATES, AND AN OXYGEN SENSOR COMPRISING PLATINUM OR PALLADIUM CYCLOHEXENOPORPHYRIN NOVARTIS AG (CH) 1998-01-29 — — WO disclosed
US-5346670-A Phthalocyanine and tetrabenztriazaporphyrin reagents BRITISH TECHNOLOGY GROUP U.S.A. INC. (US) 1994-09-13 — — US disclosed
EP-0434727-A4 RED-SHIFTED PHTHALOCYANINE AND TETRABENZTRIAZAPORPHYRIN REAGENTS ULTRA DIAGNOSTIC CORP (US) 1994-08-17 — — EP disclosed
US-5135717-A Imaging therapy BRITISH TECHNOLOGY GROUP USA INC. (US) 1992-08-04 — — US disclosed
EP-0434727-A1 RED-SHIFTED PHTHALOCYANINE AND TETRABENZTRIAZAPORPHYRIN REAGENTS BRITISH TECHNOLOGY GROUP (USA) INCORPORATED (US) 1991-07-03 — — EP disclosed
WO-1990002747-A1 RED-SHIFTED PHTHALOCYANINE AND TETRABENZTRIAZAPORPHYRIN REAGENTS ULTRA DIAGNOSTICS CORPORATION (US) 1990-03-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12616845-B2 Devices and related methods for light-based modulation of foreign body responses in living tissue CUTA, FN1, NOS2 STAT3 13/4885STAT1 10/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback